BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Mani Foroohar does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 LXEOLexeo Therapeutics, Inc. Common Stock | Buy | $18.00 | Mar 2025 | +22.4% | Miss |
 FDMT4D Molecular Therapeutics Inc | Buy | $27.00 | Jan 2025 | +47.1% | Miss |
 CAMPCAMP4 THERAPEUTICS CORPORATION | Buy | $17.00 | Nov 2024 | −54.4% | Miss |
 BNTCBenitec Biopharma Ltd ADR | Buy | $13.00 | Jul 2024 | +33.9% | Hit |
 SDGRSchrodinger Inc | Buy | $29.00 | Jul 2024 | +8.2% | Miss |
 ENGNenGene Holdings Inc. Common Stock | Buy | $31.00 | Feb 2024 | −59.7% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.